Advances in medicine.
D000748:Anemia, Macrocytic / Q000401:mortality; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002769:Cholelithiasis / Q000188:drug therapy; D002994:Clofibrate / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003911:Dextrans / Q000627:therapeutic use; D004077:Digoxin / Q000097:blood; D004358:Drug Therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006221:Halothane / Q000009:adverse effects; D006493:Heparin / Q000627:therapeutic use; D006511:Hepatitis B Antigens; D006801:Humans; D006980:Hyperthyroidism / Q000532:radiotherapy; D007456:Iodine Isotopes / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy; D009203:Myocardial Infarction / Q000188:drug therapy; D010973:Platelet Adhesiveness / Q000187:drug effects; D011655:Pulmonary Embolism / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy; D014688:Venoms / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D003911:Dextrans; D005343:Fibrinolytic Agents; D006511:Hepatitis B Antigens; D007456:Iodine Isotopes; D014688:Venoms; D004077:Digoxin; D006493:Heparin; D002994:Clofibrate; D001379:Azathioprine; D006221:Halothane